Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

Trial Profile

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2018

At a glance

  • Drugs Naltrexone (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 31 May 2017 According to an Immune Therapeutics media release, The company is ready to submit a New Drug Application (NDA) to the Directorate of Pharmacy and Medicines. The application will include results of four phase II clinical trials and one bridging trial clinical trial.
    • 22 May 2012 Results presented at Digestive Disease Week 2012.
    • 18 May 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top